Worldwide Clinical Trials Names Stephen Rayda as First Chief Digital & Information Officer to Enhance Tech and Innovation

Worldwide Clinical Trials Appoints Stephen Rayda as Its First-Ever Chief Digital & Information Officer RESEARCH TRIANGLE PARK, N.C. — Worldwide Clinical Trials, a leading global contract research organization (CRO), has announced the appointment of Stephen Rayda as its first Chief Digital & Information Officer (CDIO). This new leadership role underscores the company’s commitment to enhancing its technology and innovation, ultimately driving customer success, global trial efficiency, and a superior employee experience. Rayda will be responsible for shaping Worldwide’s enterprise technology strategy and envisioning its digital future. His primary objectives include expanding technological capabilities, streamlining operational efficiencies, and ensuring seamless workflows to improve the organization's ability to meet and exceed customer expectations. Additionally, he aims to leverage advanced technologies to accelerate the delivery of life-changing therapies, especially in critical areas like rare disease research. "Stephen’s appointment as our first Chief Digital & Information Officer marks a significant milestone for Worldwide," said Peter Benton, President and CEO of Worldwide Clinical Trials. "His extensive knowledge of healthcare technology and his track record of initiating transformative changes will be crucial as we continue to innovate and deliver unparalleled service." Rayda is passionate about using cutting-edge technologies to speed up the development of vital treatments. "Our goal is to harness data and AI to streamline clinical studies, fostering greater confidence in positive and predictable outcomes," he stated. "I’m particularly dedicated to advancing rare disease research, a field that holds personal significance for me. Collaborating with our customers, we aim to make meaningful strides in global healthcare." Rayda brings over two decades of experience in healthcare technology and operations to his new position. Most recently, he served as Executive Vice President of Global Enterprise Systems at Syneos Health, where he managed corporate systems, infrastructure, and security. Prior to that, he held prominent roles as Global Head of Infrastructure and Client Services at Mundipharma IT Services and Chief Technology Officer at Purdue Pharma. About Worldwide Clinical Trials: Worldwide Clinical Trials (Worldwide) is a full-service global CRO that partners with biotechnology and pharmaceutical companies to develop and bring new medications to market. The organization offers a wide range of capabilities, including bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies. These services are supported by a team of experienced clinicians, scientists, and researchers who bring hands-on expertise and a collaborative approach to each clinical program. Worldwide is therapeutically focused on key areas such as neuroscience, oncology, rare diseases, and cardiometabolic and inflammatory diseases. With a global presence spanning over 60 countries and more than 3,500 team members, the company is well-equipped to tackle the most complex challenges in drug development. To learn more about Worldwide Clinical Trials, visit www.worldwide.com. This appointment will likely result in improved customer service and enhanced global connectivity, enabling Worldwide to coordinate and execute clinical trials more effectively and efficiently.